The Molecular Imaging Market is a segment of the healthcare industry dedicated to advanced diagnostic techniques that enable visualization and characterization of biological processes at the molecular and cellular levels within the human body. This field merges the principles of molecular biology with medical imaging to provide valuable insights into various diseases, aiding in early diagnosis, treatment planning, and monitoring of therapeutic interventions.
In 2023, the global molecular imaging market is expected to be worth US$ 5,437.2 million. During the forecast period, the market is expected to grow at an 11.0% CAGR and generate US$ 15,457.48 million. The increasing incidences of chronic illness around the world can be attributed to the market’s growth.
To get a sample copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-724
The need for early illness diagnosis is increasing due to the rising incidence of numerous chronic diseases like cancer and other genetic disorders, which is anticipated to fuel the expansion of the worldwide market.
According to data from the Centers for Disease Control and Prevention (CDC) from February 2018, over 22,000 men and 9,000 women in the United States are diagnosed with liver cancer each year, and approximately 16,000 men and 8,000 women pass away from the disease. In addition, the market’s revenue growth is fueled by the rapid progress of molecular imaging technologies.
In the biomedical business, immune-PET, for instance, has considerably improved early cancer cell identification, enabling more use. The clinical benefit of targeted treatment using monoclonal antibodies is maximized by selecting the proper medication for the right patient.
Immune PET imaging makes it possible to assess these drugs’ in vivo biodistribution and tumor targeting to predict their toxicity and effectiveness, guide drug research, and provide specialized care. As a molecular imaging biomarker for assessing target expression and tumor targeting, radio-labeled monoclonal antibodies enable viewing and measurement of the tracer uptake.
Key Takeaways:
- In 2022, North America’s molecular imaging market expanded, with a CAGR of 35.1%.
- In 2022, the United States developed the molecular imaging business with a share of 22.6%.
- The molecular imaging market grew considerably to US$ 4,855.5 million in 2022.
- The molecular imaging market expanded with a CAGR of 9.3% between 2018 to 2022.
- By 2033, China’s molecular imaging market is projected to develop with a CAGR of 10.3%.
- By 2033, India’s molecular imaging industry is projected to expand with a CAGR of 11%.
- Japan’s molecular imaging industry grew significantly, with a 3.6% share in 2022.
- Australia’s molecular imaging market is likely to expand with a CAGR of 12.7% by 2033.
- Germany’s molecular imaging business grew, with a share of 6.9% in 2022
- In 2022, based on modality, SPECT dominated the market, with a share of 23.5%.
- In 2022, the hospital’s segment led the market, with a share of 56.5%, based on the end user.
Uncover Your Path to Optimal Wellness Now! Dive into Molecular Imaging Market Analysis with Exclusive Discounts – Click Here to Check Out and Seize Insights and Opportunities Today: https://www.futuremarketinsights.com/checkout/724
Key Players in the Molecular Imaging Market:
- Hermes Medical Solutions
- Bruker Corporation
- GE Company
- Fujifilm Holdings Corp.
- Koninklijke Philips N.V.
- Siemens AG
- Toshiba Medical System Corp.
- Mirada Medical Limited
- Carestream Health, Inc.
- Esaote SpA
- Positron Corporation
- Medisco Ltd.
- Hitachi Medical Corp.
- MIM Software Inc.
Molecular Imaging Market Segmentation:
By Modality:
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
By End Users:
- Hospitals
- Diagnostic Imaging Centres
- Ambulatory Surgical Centres
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa (MEA)
Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:
Medical Hyperspectral Imaging Market Analysis: Expanding at a CAGR of 6.2%, the global medical hyperspectral imaging market is projected to increase from a valuation of US$ 181.8 Million in 2022 to US$ 294.7 Million by the end of 2030.
Portable Medical Devices Market Sales: The global portable medical devices market is projected to expand at a CAGR of 10.7% during the forecast period. The market is estimated to generate market revenue of US$ 163.84 billion by 2033, increasing from US$ 59.28 billion in 2023.
Electronic Medical Records (EMR) Market Revenue: The global electronic medical records (EMR) market size is estimated to be valued at US$ 17.6 billion in 2023 and is projected to surpass a valuation of US$ 32.3 billion by 2033.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Modality, Application, Region and End Users over the next 10 years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Old Source: With 5.41% CAGR, Molecular Imaging Market Size to Hit US$ 7.3 Billion by 2032 | Future Market Insights
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
The post Molecular Imaging Market Paves the Way with Non-Invasive Techniques, Anticipated CAGR of 11.0% by 2033, Says FMI appeared first on Future Market Insights.
